The Role of Aldosterone in the Metabolic Syndrome
- 30 January 2011
- journal article
- review article
- Published by Springer Nature in Current Hypertension Reports
- Vol. 13 (2) , 163-172
Abstract
The metabolic syndrome associates metabolic abnormalities such as insulin resistance and dyslipidemia with increased waist circumference and hypertension. It is a major public health concern, as its prevalence could soon reach 30% to 50% in developed countries. Aldosterone, a mineralocorticoid hormone classically involved in sodium balance regulation, is increased in patients with metabolic syndrome. Besides its classic actions, aldosterone and mineralocorticoid receptor (MR) activation affect glucose metabolism, inducing insulin resistance through various mechanisms that involve oxidative stress, inflammation, and downregulation of proteins involved in insulin signaling pathways. Aldosterone and MR signaling exert deleterious effects on the cardiovascular system and the kidney that influence the cardiovascular risk associated with metabolic syndrome. Salt load plays a major role in cardiovascular injury induced by aldosterone and MR signaling. Large multicenter, randomized clinical trials testing the beneficial effects of MR antagonists on cardiovascular events and mortality in patients with metabolic syndrome are needed.Keywords
This publication has 70 references indexed in Scilit:
- Aldosterone: A cardiovascular risk factor?Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Aldosterone Production and Insulin Resistance in Healthy AdultsThe Journal of Clinical Endocrinology & Metabolism, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- Aldosterone Inhibits Insulin-Induced Glucose Uptake by Degradation of Insulin Receptor Substrate (IRS) 1 and IRS2 via a Reactive Oxygen Species-Mediated Pathway in 3T3-L1 AdipocytesEndocrinology, 2008
- Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 ratAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Mineralocorticoid Receptor Blockade Reverses Obesity-Related Changes in Expression of Adiponectin, Peroxisome Proliferator-Activated Receptor-γ, and Proinflammatory AdipokinesCirculation, 2008
- Aldosterone Inhibits Uncoupling Protein-1, Induces Insulin Resistance, and Stimulates Proinflammatory Adipokines in AdipocytesHormone and Metabolic Research, 2005
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- In vitro effects of insulin on aldosterone production in rat zona glomerulosa cellsLife Sciences, 1992
- The Effect of Weight Reduction on Blood Pressure, Plasma Renin Activity, and Plasma Aldosterone Levels in Obese PatientsNew England Journal of Medicine, 1981